Efficacy of pneumococcal vaccination in chronic lymphocytic leukemia: Should we rely on surrogate markers?

Vaccine

Volumn 26, Issue 11, 2008, Pages 1407-

  Smolej, Lukas ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; CHRONIC LYMPHATIC LEUKEMIA; DRUG EFFICACY; FOLLOW UP; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; LETTER; MORBIDITY; MORTALITY; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; VACCINATION;

BIOLOGICAL MARKERS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES;

EID: 39749083844     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.01.010     Document Type: Letter

References (1)

1. Sinisalo M., Vilpo J., Itälä M., Väkeväinen M., Taurio J., and Aittoniemi J. Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia. Vaccine 26 1 (2007) 82-87